Articles Tagged With:
-
Comprehensive Sexual Health Education Can Be Successfully Implemented with Rural Latino Youth
A reproductive health team at the University of California, San Francisco has been working for five years with community partners in rural, farming communities to provide sexual health and education to the young people living in agricultural communities. Their efforts resulted in successful implementation of comprehensive sexual health education among Latino youth.
-
Evaluation and Management of Abnormal Uterine Bleeding in Nonpregnant Patients: A Detailed Review
Vaginal bleeding in the nonpregnant patient may be due to various etiologies, including structural abnormalities, dysfunctional bleeding, disorders of menstruation, trauma, or coagulopathy. Emergency department assessment and management includes a thorough history and physical examination, stabilization, diagnostic studies, treatment, and appropriate disposition.
-
Clinicians Need to Know More About the Menstrual Health Apps Patients Use
Period-tracking apps are increasingly popular among reproductive-age women in the United States and elsewhere in the world. A new study suggests that healthcare providers should educate themselves about the apps’ functionality, inclusiveness, and health education information before recommending a menstrual app to patients.
-
Changes in Postpartum Permanent Contraception Decision-Making
Requests for permanent contraception among women have increased since June 2022. OB/GYNs report in a new study that their patients often bring up threats to their reproductive health autonomy as a reason for requesting a permanent contraception procedure.
-
Using Ultrasound in the Care of Pediatric Trauma Patients
Trauma is the leading cause of morbidity and mortality in pediatric patients in the United States, with the majority of cases resulting from blunt mechanisms such as motor vehicle accidents. Early diagnosis of life-threatening injuries is critical, and ultrasound has emerged as a valuable point-of-care tool that offers rapid, noninvasive, and radiation-free assessment at the bedside.
-
Pediatric Genitourinary Trauma
Although genitourinary trauma is uncommon, it can have devastating consequences, both physical and psychological. Clinicians need to be prepared with the knowledge needed to optimize the outcome for each child with trauma to this very sensitive area.
-
Lenacapavir Injection and Tablets (Yeztugo)
The U.S. Food and Drug Administration has approved lenacapavir, a potent, first-in-class, capsid inhibitor, for reducing the risk of sexually acquired human immunodeficiency virus type 1.
-
Does Lipoprotein(a) Improve the Risk Calculation of the PREVENT Equation?
A pooled cohort from the Multi-Ethnic Study of Atherosclerosis and the United Kingdom Biobank study has shown that, overall, the American Heart Association PREVENT risk scores performed well at predicting atherosclerotic cardiovascular disease risk even in those with high lipoprotein(a) levels, but considering lipoprotein(a) in those with low PREVENT scores may help make therapeutic decisions in these individuals.
-
Updated Recommendations for Drug-Susceptible and Drug-Resistant Tuberculosis
The authors provide an update of recommendations for the treatment of tuberculosis, including cases with drug resistance. The recommendations include the use of newer drugs that have undergone clinical trials and shorter durations of therapy.
-
Restricting Remdesivir in an Immune Era: No Harm, Big Savings
A quasi-experimental, eight-hospital, pre-post restriction of remdesivir to only symptomatic, oxygen-requiring, immunocompromised adults during July 2023 to June 2024 led to a 90% reduction in remdesivir use (37.7% to 4.1%) without any increase in 14- or 28-day all-cause mortality, 30-day readmission, or hospital length of stay. Medium- and high-risk covariate models confirmed no mortality signal, while an intriguing rise in intensive care unit admission and mechanical ventilation use among the few post-intervention recipients was most consistent with residual confounding and confounding by indication (i.e., the sickest patients being channeled to receive therapy). In an era of widespread hybrid immunity from Omicron-descended variants, broad remdesivir formulary restriction can be implemented safely and can yield substantial cost savings without compromising outcomes.